Genome doubling shapes the evolution and prognosis of advanced cancers

Craig M. Bielski(Memorial Sloan Kettering Cancer Center), Ahmet Zehir(Memorial Sloan Kettering Cancer Center), Alexander Penson(Memorial Sloan Kettering Cancer Center), Mark T.A. Donoghue(Memorial Sloan Kettering Cancer Center), Walid K. Chatila(Memorial Sloan Kettering Cancer Center), Joshua Armenia(Memorial Sloan Kettering Cancer Center), Matthew T. Chang(Memorial Sloan Kettering Cancer Center), Alison M. Schram(Memorial Sloan Kettering Cancer Center), Philip Jonsson(Memorial Sloan Kettering Cancer Center), Chaitanya Bandlamudi(Memorial Sloan Kettering Cancer Center), Pedram Razavi(Memorial Sloan Kettering Cancer Center), Gopa Iyer(Memorial Sloan Kettering Cancer Center), Mark E. Robson(Memorial Sloan Kettering Cancer Center), Zsofia K. Stadler(Memorial Sloan Kettering Cancer Center), Nikolaus Schultz(Memorial Sloan Kettering Cancer Center), José Baselga(Memorial Sloan Kettering Cancer Center), David B. Solit(Memorial Sloan Kettering Cancer Center), David M. Hyman(Memorial Sloan Kettering Cancer Center), Michael F. Berger(Memorial Sloan Kettering Cancer Center), Barry S. Taylor(Memorial Sloan Kettering Cancer Center)
Nature Genetics
July 13, 2018
Cited by 686

Abstract


Related Papers